- Home
- ODV vs HUMA Comparison
ODV vs HUMA Comparison
Compare ODV & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODV
- HUMA
- Stock Information
- Founded
- ODV 2005
- HUMA 2004
- Country
- ODV Canada
- HUMA United States
- Employees
- ODV N/A
- HUMA N/A
- Industry
- ODV Precious Metals
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- ODV Basic Materials
- HUMA Health Care
- Exchange
- ODV Nasdaq
- HUMA Nasdaq
- Market Cap
- ODV 338.9M
- HUMA 250.2M
- IPO Year
- ODV N/A
- HUMA N/A
- Fundamental
- Price
- ODV $2.72
- HUMA $1.51
- Analyst Decision
- ODV
- HUMA Strong Buy
- Analyst Count
- ODV 0
- HUMA 8
- Target Price
- ODV N/A
- HUMA $10.88
- AVG Volume (30 Days)
- ODV 1.1M
- HUMA 5.9M
- Earning Date
- ODV 08-12-2025
- HUMA 08-11-2025
- Dividend Yield
- ODV N/A
- HUMA N/A
- EPS Growth
- ODV N/A
- HUMA N/A
- EPS
- ODV N/A
- HUMA N/A
- Revenue
- ODV $5,147,156.00
- HUMA $818,000.00
- Revenue This Year
- ODV $381.12
- HUMA N/A
- Revenue Next Year
- ODV $256.81
- HUMA $949.92
- P/E Ratio
- ODV N/A
- HUMA N/A
- Revenue Growth
- ODV N/A
- HUMA N/A
- 52 Week Low
- ODV $1.16
- HUMA $1.15
- 52 Week High
- ODV $2.91
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- ODV 60.30
- HUMA 36.87
- Support Level
- ODV $2.43
- HUMA $1.43
- Resistance Level
- ODV $2.91
- HUMA $1.67
- Average True Range (ATR)
- ODV 0.14
- HUMA 0.15
- MACD
- ODV 0.02
- HUMA -0.01
- Stochastic Oscillator
- ODV 64.08
- HUMA 23.32
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.